Xcout Intel
Cidara Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Cidara Therapeutics, Inc. among biopharmaceuticals companies — ranked by similarity to what Cidara Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Cidara Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc. is a biotechnology company focused on developing late-phase antiviral and immunotherapy agents, with operations based in San Diego, California and Rahway, New Jersey.
Cidara Therapeutics, Inc. at a glance
Cidara Therapeutics, Inc. is a biopharmaceuticals company headquartered in United States. It has raised at least $312.8M across the 5 funding rounds on record. Its most recent funding round raised $240M in April 2024. Xcout tracks 1 named person at Cidara Therapeutics, Inc., including Rob Davis (chairman of the board and chief executive officer).
Cidara Therapeutics, Inc. leadership
- Rob Davischairman of the board and chief executive officer
Cidara Therapeutics, Inc. funding rounds
At least $312.8M raised across the 5 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $240M | — | |
| SEC Form D filing | $9M | — | |
| SEC Form D filing | $1.6M | — | |
| SEC Form D filing | $20.2M | — | |
| SEC Form D filing | $42M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Cidara Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Cidara Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biopharma
Amplyx Pharmaceuticals, Inc. was a San Diego-based clinical-stage biotechnology company developing treatments for serious and potentially life-threatening fungal infections. Its lead investigational drug, fosmanogepix, was acquired by Pfizer when Pfizer acquired Amplyx in 2021 and is being developed for patients with invasive fungal diseases.
Similar biopharmaceuticals company
Chimerix, Inc. is a biopharmaceutical company that develops medicines for oncology and other critical illnesses, serving US-based healthcare audiences and patients.
Similar biopharmaceuticals company
ChemoCentryx, Inc. is a biopharmaceutical company with its corporate headquarters and principal place of business located in California.
Similar biopharmaceuticals company
Achaogen Inc was a biopharmaceutical company headquartered in South San Francisco, California. The company focused on discovering, developing, and commercializing novel antibacterial treatments.
Biopharmaceutical
F2G is a biotechnology research company headquartered in the UK with subsidiaries in the US and Austria. The company specializes in developing novel therapeutics and antifungal treatments for rare fungal infections.
Similar biopharmaceuticals company
Amicus Therapeutics, Inc. is an American biopharmaceutical company based in Princeton, New Jersey, dedicated to advancing therapies to treat rare diseases.
Drug Discovery
Kanvas Biosciences, Inc. is a for-profit research and development company founded in 2020 and based in New Jersey that operates in the healthcare and biotechnology sectors.
Biopharmaceutical
Aviceda Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, focused on glyco-immune checkpoint therapeutics. The company develops novel, immune-mediated therapies designed to treat inflammatory and blinding diseases. Their proprietary technology platform leverages glycobiology to modulate the immune system for patient benefit.
Similar biopharmaceuticals company
Dermira, Inc. is a biotechnology company focused on medical dermatology, with its main headquarters located in Menlo Park, California, United States.
Similar biopharmaceuticals company
CAGE Bio is a clinical-stage biotechnology company that develops localized therapies for dermatology, inflammation, and immunology. The company utilizes a proprietary deep eutectic ionic liquid platform to enable the skin penetration of small and large molecules, providing topical treatments designed to avoid the side effects of systemic drug exposure.
Similar biopharmaceuticals company
Alpine Immune Sciences, Inc. is a publicly traded clinical-stage biopharmaceutical company founded in 2015. Headquartered in Seattle, Washington, the company focuses on discovering and developing innovative immunotherapies.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Cidara Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Cidara Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →